Biodistribution of131I-labeled anti-CK8 monoclonal antibody in HNSCC in xenotransplanted SCID mice

Anticancer Research

Volumn 31, Issue 10, 2011, Pages 3315-3321

  Andratschke, Michaela ^a,b   Luebbers, Christian W ^a   Johannson, Veronika ^c   Schmitt, Baerbel ^c   Mack, Brigitte ^c   Zeidler, Reinhard ^d   Lang, Stephan ^e   Wollenberg, Barbara ^b   Gildehaus, Franz Josef ^c  

^a Dachau Medical Center   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d Helmholtz Research Center   (Germany)

^e UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Cytokeratin 8; HNSCC; Radio labeled monoclonal antibody; Radioimmunotherapy; SCID mice; Xenografts

Indexed keywords

ANTI CYTOKERATIN 8 MONOCLONAL ANTIBODY; ANTIGEN; IODINE 131; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; CYTOKERATIN 8; RADIOACTIVE IODINE; TUMOR ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; DRUG ACCUMULATION; DRUG ACTIVITY; DRUG DISTRIBUTION; DRUG LABELING; HALF LIFE TIME; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; MAXIMUM TOLERATED DOSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOLID TUMOR; SQUAMOUS CELL CARCINOMA; ANIMAL; ANTIBODY SPECIFICITY; BLOOD; DRUG SCREENING; HEAD AND NECK TUMOR; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; METABOLISM; MOUSE MUTANT; TISSUE DISTRIBUTION; XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAVENOUS; IODINE RADIOISOTOPES; ISOTOPE LABELING; KERATIN-8; MAXIMUM TOLERATED DOSE; MICE; MICE, SCID; ORGAN SPECIFICITY; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 80054723112     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Pignon JP, Bourhis J, Domenge C and Designe L: Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group: Meta-Analysis of chemotherapy on head and neck cancer. Lancet 355(9208): 949-955, 2000. (Pubitemid 30148259)
2. Forastiere AA: Is there a new role for induction chemotherapy in the treatment of head and neck cancer? J Natl Cancer Inst 96(22): 1647-1649, 2004.
3. Wollenberg B, Walz A, Kolbow K, Pauli C, Chaubal S and Andratschke M: Clinical relevance of circulating tumour cells in the bone marrow of patients with SCCHN. Onkologie 27: 358-362, 2004. (Pubitemid 39274231)
4. Chaubal S, Wollenberg B, Kastenbauer E and Zeidler R: EpCAM - a marker for the detection of disseminated tumor cells in patients suffering from SCCHN. Anticancer Res 19(3B): 2237-2242, 1999. (Pubitemid 29392527)
5. Bernier J, Bentzen SM and Vermorken JB: Molecular therapy in head and neck oncology. Nat Rev Clin Oncol 6(5): 266-277, 2009.
6. Cripps C, Winquist E, Devries MC, Stys-Norman D and Gilbert R: Epidermal growth factor receptor targeted therapy in stages III and IV head and neck cancer. Curr Oncol 17(3): 37-48, 2010.
7. Sundvall M, Karrila A, Nordberg J, Grénman R and Elenius K: EGFR targeting drugs in the treatment of head and neck squamous cell carcinoma. Expert Opin Emerg Drugs 15(2): 185-201, 2010.
8. Kaminsky MS, Estes J, Zasadny KR, Francis IR, Ross CW, Tuck M, Regan D, Fisher S, Gutierrez J, Kroll S, Stagg R, Tidmarsch G and Wahl RL: Radioimmunotherapy with iodine 131-1 tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience. Blood 96: 1259-1266, 2000. (Pubitemid 30658452)
9. Postema EJ, Boerman OC, Oyen WJ, Raemaekers JM and Corstens FH: Radioimmunotherapy of B-cell non Hodgkin's lymphoma. Eur J Nucl Med 28: 1725-1735, 2001. (Pubitemid 33036117)
10. Stroomer JW, Roos JC, Sproll M, Quak JJ, Heider KH, Wilhelm BJ, Casteljins JA, Meyer R, Kwakkelstein MO, Snow GB, Adolf GR and Van Dongen GAMS: Safety and biodistribution of 99m.techentium-labeled anti CD44v6 monoclonal antibody BIWA 1 in head and neck cancer patients. Clin Cancer Res 6: 3046-3055, 2000. (Pubitemid 30637727)
11. 131I-labeled anti-EpCAM monoclonal antibody. Anticancer Res 27: 431-436, 2007.
12. Chin D, Boyle GM, Porceddu S, Theile DR, Parsons PG and Coman WB: Head and neck cancer: past, present and future. Expert Rev Anticancer Ther 6(7): 1111-1118, 2006. (Pubitemid 44203388)
13. Godfroid E, Geuskens M, Dupressoir T, Parent I and Szpirer C: Cytokeratins are exposed on the outer surface of established human mammary carcinoma cells. J Cell Sci 99: 595-607, 1991.
14. Hembrough TA, Vasudevan J, Allietta MM, Glass WF II and Gonias SL: A cytokeratin 8-like protein with plasminogen-binding activity is present on the external surfaces of hepatocytes, Hep G2 cells and breast carcinoma cell lines. J Cell Sci 108(Pt 3): 1071-1082, 1995.
15. Gires O, Munz M, Schaffrik M, Kie u C, Rauch J, Ahlemann M, Mack B, Wollenberg B, Lang S, Hofmann T, Hammerschmidt W and Zeidler R: Profile identification of disease-associated humoral antigens by AMIDA, a novel proteomics-based technology. Cell Mol Life 61(10): 1198-1207, 2006.
16. Rauch J, Ahlemann M, Schaffrik M, Mack B, Ertongur S, Andratschke M, Zeidler R, Lang S and Gires O: Allogenic antibody-mediated identification of head and neck cancer antigens. Biochem Biophys Res Commun 323(1): 156-162, 2004. (Pubitemid 39200663)
17. Gires O, Andratschke M, Schmitt B, Mack B and Schaffrik M: Cytokeratin 8 associates with the external leaflet of plasma membranes in tumour cells. Biochem Biophys Res Commun 328(4): 1154-1162, 2005. (Pubitemid 40238755)
18. Gires O, Mack B, Rauch J and Matthias C: CK8 correlates with malignancy in leukoplakia and carcinoma of the head and neck. Biochem Biophys Res Commun 343(1): 252-259, 2006.
19. Matthias C, Mack B, Berghaus A and Gires O: Keratin 8 expression in head and neck epithelia. BMC Cancer 8: 267, 2008.
20. Weadock KS, Sharkey RM, Varga DC and Goldenberg DM: Evaluation of a remote radioiodination system for radioimmunotherapy. J Nucl Med 31(4): 508-511, 1990. (Pubitemid 20144720)
21. Tsai SW, Sun YY, Williams LE, Raubitschek AA, Wu AM and Shively JE: Biodistribution and radioimmunotherapy of human breast cancer xenografts with radiometal-labeled DOTA conjugated anti-HER2/neu antibody 4D5. Bioconjug Chem 11(3): 327-334, 2000. (Pubitemid 30324898)
22. Reddy N, Ong GL, Behr TM, Sharkey RM, Goldenberg DM and Mattes MJ: Rapid blood clearance of mouse IgG2a and human IgG1 in many nude and nu/+ mouse strains is due to low IgG2a serum concentrations. Cancer Immunol Immunother 46(1): 25-33, 1998. (Pubitemid 28133402)
23. Michel RB, Ochakovskaya R and Mattes MJ: Rapid blood clearance of injected mouse IgG2a in SCID mice. Cancer Immunol Immunother 51(10): 547-556, 2002. (Pubitemid 35232004)
24. 131I-labelled antibodies and their fragments in the GW-39 colonic cancer xenograft model. Int J Cancer 44(2): 292-300, 1989.
25. Jain M, Chauhan SC, Singh AP, Venkatraman G, Colcher D and Batra SK: Penetratin improves tumor retention of single-chain antibodies: a novel step toward optimization of radioimmunotherapy of solid tumors. Cancer Res 65(17): 7840-7846, 2005. (Pubitemid 41297260)
26. Quadri SM, Malik AB, Chu HB, Freedman RS and Vriesendorp HM: Intraperitoneal indium-111- and yttrium-90-labeled human IgM (AC6C3-2B12) in nude mice bearing peritoneal carcinomatosis. J Nucl Med 37(9): 1545-1551, 1996. (Pubitemid 26321645)
27. Zamora PO, Gulhke S, Bender H, Diekmann D, Rhodes BA, Biersack HJ and Knapp FF Jr: Experimental radiotherapy of receptor-positive human prostate adenocarcinoma with 188Re-RC-160, a directly-radiolabeled somatostatin analogue. Int J Cancer 65(2): 214-220, 1996.
28. Janssen ML, Pels W, Massuger LF, Oyen WJ, Boonstra H, Corstens FH and Boerman OC: Intraperitoneal radioimmunotherapy in an ovarian carcinoma mouse model: effect of the radionuclide. Int J Gynecol Cancer 13(5): 607-613, 2003. (Pubitemid 38222601)
29. Koppe MJ, Soede AC, Pels W, Oyen WJ, Goldenberg DM, Bleichrodt RP and Boerman OC: Experimental radioimmunotherapy of small peritoneal metastases of colorectal origin. Int J Cancer 106(6): 965-972, 2003. (Pubitemid 37071679)